melanoma

Biotech

Have mRNA cancer vaccines arrived? Biopharma execs weigh in

Executives from BMS, Regeneron, Roche's Genentech and more weighed in on the future of cancer vaccines after recent positive readouts.
Angus Liu Jan 25, 2023 10:30am

Moderna, Merck & Co. cancer vaccine slashes melanoma recurrence

Dec 13, 2022 8:25am

Erasca slides a Novartis melanoma med into pipeline for $20M

Dec 9, 2022 10:50am

Instil Bio takes the ax to its lead asset, cuts 60% of its staff

Dec 8, 2022 10:24am

Making melanoma cells immortal comes down to gene mutation synergies

Nov 10, 2022 2:00pm

Merck ditches Cavatak more than 4 years after buying Viralytics

Oct 27, 2022 10:40am